Immunomodulatory effects of lenvatinib in patients with advanced thyroid cancer

Authors

Institutions

Publication Details

Journal
Cancer Immunology Immunotherapy
Published
2025-12-19
DOI
https://doi.org/10.1007/s00262-025-04241-7
Primary Topic
Thyroid Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Immunomodulatory effects of lenvatinib in patients with advanced thyroid cancer

Janneke E. W. Walraven, Pepijn van Houten, Chunying Peng, Petronella B. Ottevanger et al.
Cancer Immunology Immunotherapy
Thyroid Cancer Diagnosis and Treatment
article

Immunomodulatory effects of lenvatinib in patients with advanced thyroid cancer

Janneke E. W. Walraven, Pepijn van Houten, Chunying Peng, Petronella B. Ottevanger, Romana Teodora Netea-Maier, Liesbeth van Emst, Martin Jaeger, Prashant Changoer
article en

Abstract

No abstract available for this paper.
Cancer Immunology ImmunotherapyVol. 75(1)
Radboud University Nijmegen (NL), Iuliu Hațieganu University of Medicine and Pharmacy (RO), Radboud University Medical Center (NL), Radboud Institute for Molecular Life Sciences (NL)
Eisai
Openalex Percentile: Top 46%
Thyroid Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.